Skip to main content

Gaviscon-2 Disease Interactions

There are 2 disease interactions with Gaviscon-2 (alginic acid / aluminum hydroxide / magnesium trisilicate).

Major

Aluminum-containing antacids (applies to Gaviscon-2) constipation

Major Potential Hazard, High plausibility. Applicable conditions: Renal Dysfunction, Intestinal Obstruction, Phosphate Imbalance

Aluminum containing antacids may produce constipation, which may lead to intestinal obstruction. Osteomalacia and hypophosphatemia may be produced in patients with renal dysfunction who are not receiving dialysis. Patients with renal dysfunction, intestinal obstruction, osteomalacia, or hypophosphatemia should use antacids with low or no aluminum content.

References

  1. "Product Information. Amphojel (aluminum hydroxide)." Wyeth-Ayerst Laboratories (2001):
  2. "Product Information. Rolaids (dihydroxyaluminum sodium carbonate)." Warner Lambert Consumer Healthcare (2001):
  3. "Product Information. Losospan (magaldrate)." Whitehall-Robbins (2001):
Major

Magnesium salts (applies to Gaviscon-2) renal dysfunction

Major Potential Hazard, High plausibility.

Magnesium is eliminated by the kidney. The serum concentration of magnesium is increased in patients with renal impairment. Magnesium toxicity includes CNS depression, muscular paralysis, respiratory depression, hypotension and prolonged cardiac conduction time. Disappearance of the patellar reflex is a useful clinical sign of magnesium intoxication. Therapy with magnesium should be administered cautiously and dosages should be modified in patients with compromised renal function. Clinical monitoring of serum magnesium levels is recommended.

References

  1. "Product Information. Mag-Ox 400 (magnesium oxide)." Blaine Company Inc. (2001):
  2. "Product Information. Uro-Mag (magnesium oxide)." Blaine Company Inc. (2001):
  3. "Product Information. Slow-Mag (magnesium chloride)." Searle (2001):
  4. "Product Information. Magonate (magnesium gluconate)." Fleming and Company (2001):
  5. "Product Information. Losospan (magaldrate)." Whitehall-Robbins (2001):
View all 5 references

Gaviscon-2 drug interactions

There are 244 drug interactions with Gaviscon-2 (alginic acid / aluminum hydroxide / magnesium trisilicate).

Gaviscon-2 alcohol/food interactions

There is 1 alcohol/food interaction with Gaviscon-2 (alginic acid / aluminum hydroxide / magnesium trisilicate).


Report options

Share by QR Code
QR code containing a link to this page

More about Gaviscon-2 (alginic acid / aluminum hydroxide / magnesium trisilicate)

Professional resources

Related treatment guides

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.